NanoGroup S.A. (WSE: NNG)

Poland flag Poland · Delayed Price · Currency is PLN
4.060
+0.120 (3.05%)
Sep 27, 2024, 5:00 PM CET
339.39%
Market Cap 98.34M
Revenue (ttm) -24.98K
Net Income (ttm) -7.35M
Shares Out 24.22M
EPS (ttm) -0.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 149,475
Open 3.940
Previous Close 3.940
Day's Range 3.900 - 4.240
52-Week Range 0.850 - 4.370
Beta 1.00
Analysts n/a
Price Target n/a
Earnings Date Sep 20, 2024

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Country Poland
Stock Exchange Warsaw Stock Exchange
Ticker Symbol NNG
Full Company Profile

Financial Performance

In 2023, NanoGroup's revenue was 2,019, a decrease of -98.55% compared to the previous year's 139,549. Losses were -7.89 million, 840.8% more than in 2022.

Financial Statements

News

There is no news available yet.